(Q43672165)

25 November 2017

1 reference

title

Gender differences in the cardiovascular effect of sex hormones (English)

1 reference

25 November 2017

1 reference

Cristiana Vitale

1

1 reference

25 November 2017

Michael E Mendelsohn

series ordinal

2

1 reference

25 November 2017

Giuseppe M C Rosano

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

30 June 2009

1 reference

Nature Reviews Cardiology

25 November 2017

1 reference

25 November 2017

6

1 reference

25 November 2017

8

1 reference

25 November 2017

532-542

1 reference

https://scigraph.springernature.com/pub.10.1038/nrcardio.2009.105

25 November 2017

0 references

cites work

Menopause and risk of cardiovascular disease: the Framingham study.

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Gender differences in the regulation of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Acute anti-ischemic effect of testosterone in men with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: evidence of a direct calcium antagonism action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estrogens, menopause, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estradiol and metabolic syndrome in older italian men: The InCHIANTI Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Lipoprotein particle concentrations may explain the absence of coronary protection in the women's health initiative hormone trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Type II diabetes abrogates sex differences in endothelial function in premenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Renin angiotensin system and gender differences in the cardiovascular system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Changes in the renin-angiotensin-aldosterone axis in later life

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Salt sensitivity and hypertension after menopause: role of nitric oxide and angiotensin II.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Serum lipoproteins and endogenous sex hormones in early life: observations in children with different lipoprotein profiles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Cholesterol screening in childhood: results of a 9-year follow-up study in Swiss and Italian children in Switzerland.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Growth hormone and sex steroids. Interactions in puberty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Androgens, insulin resistance and vascular disease in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Influence of menopause on blood cholesterol levels in women: the role of body composition, fat distribution and hormonal milieu. Virgilio Menopause Health Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Androgens and coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Androgens and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

The effects of testosterone on insulin sensitivity in male rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Endogenous sex hormones in men aged 40-80 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

The influence of aging on plasma sex hormones in men: the Telecom Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Molecular and cellular basis of cardiovascular gender differences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estrogen acutely increases peripheral blood flow in postmenopausal women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Effect of acute administration of estradiol 17 beta on aortic blood flow in menopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Acute administration of 17beta-estradiol reduces endothelin-1 release during pacing-induced ischemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Effect of estradiol 17beta upon coronary artery vasoconstrictor response to methylergometrine maleate in female menopausal patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estrogen receptor beta dominates in baboon carotid after endothelial denudation injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Effect of testosterone and estradiol in a man with aromatase deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Localized expression of aromatase in human vascular tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Endogenous Estrogens Influence Endothelial Function in Young Men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

The protective effects of estrogen on the cardiovascular system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Time since menopause influences the acute and chronic effect of estrogens on endothelial function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estrogen actions and in situ synthesis in human vascular smooth muscle cells and their correlation with atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estrogen therapy and coronary-artery calcification.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

The influence of testosterone upon vascular reactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Vascular reactivity is impaired in genetic females taking high-dose androgens.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Atherosclerosis in apolipoprotein E-deficient mice is decreased by the suppression of endogenous sex hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

The degree of coronary atherosclerosis in bilaterally oophorectomized women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoE-/- mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Low serum testosterone and mortality in male veterans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Low serum testosterone and mortality in older men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

The association of hypotestosteronemia with coronary artery disease in men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Increased carotid atherosclerosis in andropausal middle-aged men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Endogenous hormones and carotid atherosclerosis in elderly men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Endogenous sex hormones and progression of carotid atherosclerosis in elderly men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Low testosterone levels are associated with coronary artery disease in male patients with angina

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Polycystic ovary syndrome: a risk factor for cardiovascular disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Cardiovascular risk in women with polycystic ovary syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Mortality and morbidity in transsexual subjects treated with cross-sex hormones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Guidelines for the hormone treatment of women in the menopausal transition and beyond. Position statement by the Executive Committee of the International Menopause Society.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Metabolic and vascular effect of progestins in post-menopausal women. Implications for cardioprotection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Factors influencing long-term prognosis after recovery from myocardial infarction—Three-year findings of the Coronary Drug Project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Risks of testosterone-replacement therapy and recommendations for monitoring

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.105

Blood pressure and endogenous testosterone in men: an inverse relationship

31 March 2020

1 reference

12 December 2020

Hormone therapy and the cardiovascular system: the critical role of progestins.

1 reference

12 December 2020

Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study.

1 reference

12 December 2020

Ischaemic heart disease in young women a re-appraisal of the sex factor

1 reference

12 December 2020

Hormone replacement therapy and coronary artery atherosclerosis: the monkey model

1 reference

12 December 2020

Atherosclerosis precursors in Finnish children and adolescents. IV. Serum lipids in newborns, children and adolescents.

1 reference

12 December 2020

Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen

1 reference

12 December 2020

Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit

1 reference

12 December 2020

Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens

1 reference

12 December 2020

Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age

1 reference

12 December 2020

ERbeta has nongenomic action in caveolae

1 reference

12 December 2020

The effects of testosterone treatment on body composition and metabolism in middle-aged obese men

1 reference

12 December 2020

Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men.

1 reference

12 December 2020

The regulation of adipose tissue distribution in humans

1 reference

12 December 2020

10.1038/NRCARDIO.2009.105

Identifiers

DOI

1 reference

Dimensions Publication ID

25 November 2017

0 references

1 reference